FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

702806008: Ruxolitinib (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2014. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3006149011 Ruxolitinib en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3006175010 Ruxolitinib (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4849151000005117 ruxolitinib da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) dansk modul

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ruxolitinib Is a Protein-tyrosine kinase inhibitor false Inferred relationship Some
Ruxolitinib Is a Antineoplastic agent (substance) true Inferred relationship Some
Ruxolitinib Is a Janus kinase inhibitor true Inferred relationship Some
Ruxolitinib Has disposition (attribute) Janus kinase inhibitor (disposition) true Inferred relationship Some
Ruxolitinib Is a kemisk stof specificeret iht. funktion false Inferred relationship Some
Ruxolitinib Is a Enzyme inhibitor false Inferred relationship Some
Ruxolitinib Is a Nitrile (substance) true Inferred relationship Some
Ruxolitinib Is a Pyrazole derivative true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing ruxolitinib (medicinal product) Has active ingredient True Ruxolitinib Inferred relationship Some 1
Product containing precisely ruxolitinib 5 milligram/1 each conventional release oral tablet Has active ingredient False Ruxolitinib Inferred relationship Some
Product containing precisely ruxolitinib 10 milligram/1 each conventional release oral tablet Has active ingredient False Ruxolitinib Inferred relationship Some
Product containing precisely ruxolitinib 20 milligram/1 each conventional release oral tablet Has active ingredient False Ruxolitinib Inferred relationship Some
Product containing precisely ruxolitinib 15 milligram/1 each conventional release oral tablet Has active ingredient False Ruxolitinib Inferred relationship Some
Product containing precisely ruxolitinib 25 milligram/1 each conventional release oral tablet Has active ingredient False Ruxolitinib Inferred relationship Some
Product containing precisely ruxolitinib 5 milligram/1 each conventional release oral tablet Has active ingredient False Ruxolitinib Inferred relationship Some 1
Product containing precisely ruxolitinib 5 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Ruxolitinib Inferred relationship Some 1
Product containing precisely ruxolitinib 10 milligram/1 each conventional release oral tablet Has active ingredient False Ruxolitinib Inferred relationship Some 1
Product containing precisely ruxolitinib 10 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Ruxolitinib Inferred relationship Some 1
Product containing precisely ruxolitinib 20 milligram/1 each conventional release oral tablet Has active ingredient False Ruxolitinib Inferred relationship Some 1
Product containing precisely ruxolitinib 20 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Ruxolitinib Inferred relationship Some 1
Product containing precisely ruxolitinib 15 milligram/1 each conventional release oral tablet Has active ingredient False Ruxolitinib Inferred relationship Some 1
Product containing precisely ruxolitinib 15 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Ruxolitinib Inferred relationship Some 1
Product containing precisely ruxolitinib 25 milligram/1 each conventional release oral tablet Has active ingredient False Ruxolitinib Inferred relationship Some 1
Product containing precisely ruxolitinib 25 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Ruxolitinib Inferred relationship Some 1
Ruxolitinib phosphate (substance) Is a False Ruxolitinib Inferred relationship Some
Product containing precisely ruxolitinib 5 milligram/1 each conventional release oral tablet Has precise active ingredient False Ruxolitinib Inferred relationship Some 1
Product containing precisely ruxolitinib 10 milligram/1 each conventional release oral tablet Has precise active ingredient False Ruxolitinib Inferred relationship Some 1
Product containing precisely ruxolitinib 20 milligram/1 each conventional release oral tablet Has precise active ingredient False Ruxolitinib Inferred relationship Some 1
Product containing precisely ruxolitinib 15 milligram/1 each conventional release oral tablet Has precise active ingredient False Ruxolitinib Inferred relationship Some 1
Product containing precisely ruxolitinib 25 milligram/1 each conventional release oral tablet Has precise active ingredient False Ruxolitinib Inferred relationship Some 1
Ruxolitinib-containing product in oral dose form Has active ingredient True Ruxolitinib Inferred relationship Some 1
Ruxolitinib phosphate (substance) Is modification of (attribute) True Ruxolitinib Inferred relationship Some
Ruxolitinib only product Has active ingredient True Ruxolitinib Inferred relationship Some 1
Ruxolitinib only product in oral dose form Has active ingredient True Ruxolitinib Inferred relationship Some 1
Product containing precisely ruxolitinib (as ruxolitinib phosphate) 5 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Ruxolitinib Inferred relationship Some 1
Ruxolitinib (as ruxolitinib phosphate) 10 mg oral tablet Has basis of strength substance (attribute) True Ruxolitinib Inferred relationship Some 1
Ruxolitinib (as ruxolitinib phosphate) 20 mg oral tablet Has basis of strength substance (attribute) True Ruxolitinib Inferred relationship Some 1
Product containing precisely ruxolitinib (as ruxolitinib phosphate) 15 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Ruxolitinib Inferred relationship Some 1
Ruxolitinib (as ruxolitinib phosphate) 25 mg oral tablet Has basis of strength substance (attribute) True Ruxolitinib Inferred relationship Some 1
Ruxolitinib withdrawal Associated with False Ruxolitinib Inferred relationship Some 1
Ruxolitinib dependence (disorder) Causative agent True Ruxolitinib Inferred relationship Some 1
ruxolitinibphosphat Is a True Ruxolitinib Inferred relationship Some

This concept is not in any reference sets

Back to Start